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Background: The prognostic importance of electrocardiographic P wave indices (PWIs), thought to reflect atrial anatomy and physiology, is unclear. 
We hypothesized that variations in clinically normal PWIs predict mortality and major cardiovascular events (MACE).
Methods and Results: We analyzed ECGs in 33,144 women enrolled in the Women’s Health Initiative clinical trials, who were without baseline 
cardiovascular disease and had normal ECGs by Minnesota and Novacode criteria. PWIs, including maximum P wave duration, maximum P wave 
area, P wave terminal force, PR duration, and P wave dispersion, were measured using computer algorithms. During a median follow-up of 8.1 years 
(range 0.3 - 11.2 years), 1,229 women died and 1,417 experienced a composite endpoint of MACE (fatal or non-fatal: myocardial infarction, stroke, 
or congestive heart failure). Each of the PWIs were studied individually in separate models. In unadjusted analyses longer maximum P wave duration, 
greater P wave terminal force, and greater P wave dispersion were associated with increased mortality as well as MACE (Log rank P value <0.001 for 
all). After adjusting for baseline demographics and clinical characteristics, PWIs significantly associated with all cause mortality were maximum P 
wave area (continuous variable, 75th vs 25th percentile HR 1.10, CI 1.01-1.19), maximum P wave terminal force (continuous variable, 75th vs 25th 
percentile HR 1.13, CI 1.02-1.26), and P wave dispersion >40 ms (categorical variable, >40 ms vs 0 ms HR 1.26, CI 1.11-1.43). Similarly, P wave 
terminal force and P wave dispersion were independently associated with MACE. However, PWIs were associated with only marginal improvements in 
discrimination (increase in c-index ranging from 0.002 to 0.003) and reclassification of mortality risk (0.8% to 3.0% decrease of relative IDI) beyond 
a model with established risk factors.
Conclusions: Quantitative P wave measures in healthy women with normal resting ECGs are independently associated with mortality as well as 
MACE, and may provide modest additional prognostic information beyond established risk factors. Future work is needed to determine the value of 
PWIs as prognostic and therapeutic markers.
